Turenne Capital
Finance · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9 Rue De Téhéran, Paris, Ile-de-France, ...Phone Number
+33 153430303Website
www.turennecapital.comRevenue
$7.8 MillionIndustry
About Turenne Capital
Is Turenne Capital your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Turenne Capital had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Turenne Capital, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Turenne Capital
Funding: Get notified immidiatlly once Turenne Capital has new funding data
Check if Turenne Capital has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Turenne Capital recently announced quarterly report
Check out if Turenne Capital is spiking on competitors!
Product Launch: Get notified when Turenne Capital launches new products
Recommended Actions
Find VP level buyers at Turenne Capital
Find more new buyers
Company Profile Activity
Activity Insights
Turenne Capital is experiencing very low activity levels compared to other companies in the Finance sector.
What does this means?
Turenne Capital is drawing exceptional interest within the Finance industry, suggesting notable developments or strong market momentum, learn more about Turenne Capital.
Turenne Capital Tech Stack
A closer look at the technologies used by Turenne Capital
Most Recent Scoops
Turenne Capital News & Media
Domain Therapeutics Raises $42m Series A Financing
STRASBOURG, France & MONTREAL--(BUSINESS WIRE)--Domain Therapeutics, a biopharmaceutical company specializing in the research and development of innovative drugs targeting G Protein-Coupled Receptors (GPCRs) in immuno-oncology, announced today the closing of a US $42m (€39m) series A financing round co-led by Panacea Venture, CTI Life Sciences and 3B Future Health Fund, and joined by adMare BioInnovations, Schroders Capital, Omnes, Turenne Capital, Theodorus, Viva BioInnovator and existing inveTherapixel raises 5 mln euro Series A
Therapixel said March 13 that it raised a 5 million euros ($5.6 million) Series A round co led by Omnes and M Capital Partners. The pool of investors include Région Sud Investissement (managed by Turenne Capital), IT-Translation and Credit Agricole (Creazur). Therapixel is developing AI-based algorithms for breast cancer screening.Teach On Mars Completes €7M Funding Round to Finance the Next-Phase Deployment of its Mobile Learning Technology
PARIS, January 24, 2019 /PRNewswire/ -- Teach on Mars, Europe's leading mobile-native learning technology provider, today announces the completion of its third round of funding, worth €7 million. This new investment is led by Omnes and Région Sud Investissement (advised by Turenne...
Top Finance Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Turenne Capital
Founded in 1999, Turenne Groupe supports companies, startups, SMEs, and mid-sized enterprises in equity financing at every stage of their development across France. The group specializes in various sectors including health, environmental services, and hospitality, with a focus on deep tech and industrial startups. They are recognized as an independ... Read More